Geode Capital Management »

Revance Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 2.3M 5.19
2024-06-30 $5.9M 2.3M 2.57
2024-03-31 $9.7M 2.0M 4.92
2023-09-30 $20M 1.8M 11.47
2023-06-30 $43M 1.7M 25.31
2023-03-31 $51M 1.6M 32.21
2022-12-31 $28M 1.5M 18.46
2022-09-30 $37M 1.4M 27.00
2022-06-30 $17M 1.2M 13.82
2022-03-31 $26M 1.3M 19.50
2021-12-31 $21M 1.3M 16.32
2021-09-30 $34M 1.2M 27.86
2021-06-30 $36M 1.2M 29.64
2021-03-31 $31M 1.1M 27.95
2020-12-31 $28M 992k 28.34
2020-09-30 $24M 941k 25.14
2020-06-30 $20M 798k 24.42
2020-03-31 $11M 724k 14.80
2019-12-31 $9.5M 587k 16.23
2019-09-30 $7.5M 577k 13.00
2019-06-30 $7.3M 561k 12.97
2019-03-31 $7.7M 488k 15.76
2018-12-31 $7.8M 386k 20.13
2018-09-30 $8.4M 338k 24.85
2018-06-30 $8.3M 304k 27.45
2018-03-31 $8.1M 262k 30.80
2017-12-31 $7.8M 220k 35.75
2017-09-30 $5.6M 203k 27.55
2017-06-30 $5.1M 192k 26.40
2017-03-31 $3.7M 178k 20.80
2016-12-31 $3.2M 153k 20.70
2016-09-30 $2.4M 148k 16.20
2016-06-30 $2.0M 144k 13.60
2016-03-31 $2.4M 140k 17.46
2015-12-31 $4.4M 129k 34.16
2015-09-30 $2.9M 97k 29.75
2015-06-30 $2.5M 77k 31.97
2015-03-31 $1.5M 71k 20.73
2014-12-31 $1.1M 65k 16.93
2014-09-30 $1.2M 63k 19.32
2014-06-30 $1.4M 41k 33.99
2014-03-31 $1.1M 35k 31.47